ArticleCancers2022

Expression of Immunomodulatory Checkpoint Molecules in Drug-Resistant Neuroblastoma: An Exploratory Study.

Nicholas J Skertich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.